Browse the latest research summaries in the field of genetics for spinal cord injury patients and caregivers.
Showing 351-360 of 1,773 results
Curr Protoc, 2023 • April 1, 2023
The study addresses the limitations of using neonatal or immortalized cells for studying adult spinal cord diseases by providing a protocol for preparing primary mixed glial cultures from adult mouse ...
KEY FINDING: This protocol provides a method for preparing mixed glial cells from adult mouse spinal cord, suitable for in vitro evaluations or further preparation of microglia-enriched and microglia-depleted cells.
Neural Regeneration Research, 2023 • March 3, 2023
This study investigates the role of EphA4 in regulating ferroptosis of spinal motor neurons following spinal cord ischemia/reperfusion injury (SCIRI) in rats. SCIRI leads to increased EphA4 expression...
KEY FINDING: Spinal cord ischemia/reperfusion injury increased EphA4 expression in the neurons of anterior horn and markedly worsened ferroptosis-related indicators.
CNS Neurosci Ther, 2023 • January 1, 2023
This study investigates the protective effects of zinc on spinal cord injury (SCI) in mice, focusing on the role of Parthanatos, a programmed cell death pathway. The research demonstrates that zinc pr...
KEY FINDING: Zinc treatment significantly increased LC3B, PINK1, and Mito-Parkin levels after spinal cord injury, suggesting an upregulation of mitophagy.
Molecular Pain, 2024 • August 24, 2024
Botulinum neurotoxin (BoNT) has emerged as a therapeutic option for pain conditions, with its pain-relieving capabilities attributed to several significant mechanisms. One crucial mechanism involves t...
KEY FINDING: BoNTs inhibit the release of neurotransmitters involved in the pain pathway, including CGRP, glutamate, substance P, and ATP, by suppressing SNARE proteins.
CNS Neuroscience & Therapeutics, 2023 • January 1, 2023
This study investigates the protective effects of Elamipretide (EPT) against spinal cord injury (SCI) by examining its impact on pyroptosis, neuroinflammation, and neuronal loss in both in vivo and in...
KEY FINDING: EPT treatment led to a significant increase in NeuN-positive cells 28 days after SCI in EPT-treated animals, indicating reduced neuronal loss.
Biology, 2023 • March 31, 2023
This study evaluates the matrisome following induction of the SNI pain model using proteomic analyses. Additionally, we studied the effectiveness of SCS using either DTMP or a conventional low-rate SC...
KEY FINDING: DTMP reversed expression levels of 83% of proteins affected by the pain model back to levels seen in uninjured animals, whereas a low-rate (LR-SCS) approach reversed 67%.
Int. J. Mol. Sci., 2023 • April 12, 2023
Edema after spinal cord injury (SCI) is a serious condition that can worsen the initial damage. The mechanisms are not fully understood but involve mechanical disruption, inflammation, and imbalances ...
KEY FINDING: Edema formation is one of the first events of the acute phase of spinal cord injury (SCI) and its mechanisms are similar in the brain and spinal cord, but structural and tissue-specific differences can affect edema formation in these two regions.
bioRxiv preprint, 2023 • April 17, 2023
The study investigated the effects of PTEN knockout (PTEN-KO) using retrogradely transported adeno-associated viruses (AAVrg) on locomotor recovery in mice with acute and chronic spinal cord injury (S...
KEY FINDING: PTEN-KO using AAVrg’s improves locomotor outcomes in both acute and chronic SCI conditions, however, the effects are severity dependent.
CNS Neurosci Ther, 2023 • January 5, 2023
The study aimed to investigate the role of ciRNA-Kat6b in neuropathic pain, identifying it as a nervous-system-specific circRNA downregulated in the dorsal spinal horn after peripheral nerve injury. R...
KEY FINDING: Peripheral nerve injury downregulates ciRNA-Kat6b in the dorsal spinal horn of male mice, and rescuing this downregulation alleviates CCI-induced pain hypersensitivities.
Virologica Sinica, 2023 • May 11, 2023
This study demonstrates that spastin is required for efficient HIV-1 replication. Knockdown of spastin inhibits the production of the intracellular HIV-1 Gag protein and new virions through enhancing ...
KEY FINDING: Knockdown of spastin inhibits HIV-1 Gag protein production and new virion formation by enhancing Gag lysosomal degradation.